Search research articles
Contact Us
Filters
Showing results (841-850 of 1,142) with videos related to
Page
of 115
Sort By:
Journal of the International Neuropsychological Society : JINS
|
February 20, 2008
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia
S Kristian Hill, John A Sweeney, Robert M Hamer, et al.
Neuroscience
|
March 28, 2006
Limited influence of olanzapine on adult forebrain neural precursors in vitro
J H Councill, E S Tucker, G T Haskell, et al.
Pacing and Clinical Electrophysiology : PACE
|
August 23, 2006
Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performance
Michael D Gammage, Randy A Lieberman, Raymond Yee, et al.
Molecular Psychiatry
|
October 30, 2013
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E M P Poels, L S Kegeles, J T Kantrowitz, et al.
Neurology
|
January 1, 2016
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients
Linda A Lieberman, Wanyong Zeng, Carol Singh, et al.
CNS Spectrums
|
December 31, 2005
From clinical research to clinical practice: a 4-year review of ziprasidone
Charles B Nemeroff, Jeffrey A Lieberman, Peter J Weiden, et al.
Journal of Clinical Microbiology
|
October 3, 2023
Evaluation of Fourier transform-infrared spectroscopy (FT-IR) as a control measure for nosocomial outbreak investigations
Gabriela Uribe, Stephen J Salipante, Lauren Curtis, et al.
British Journal of Cancer
|
August 15, 2002
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease
F H Blackhall, A D Atkinson, M B Maaya, et al.
JAMA
|
November 6, 1991
Prospective study of tardive dyskinesia incidence in the elderly
B L Saltz, M G Woerner, J M Kane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 24, 1999
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia
V S Basile, M Masellis, F Badri, et al.
Page
of 115
Search research articles
Search
Showing results (841-850 of 1,142) with videos related to
Sort By:
Page
of 115
Journal of the International Neuropsychological Society : JINS
|
February 20, 2008
Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia
S Kristian Hill, John A Sweeney, Robert M Hamer, et al.
Neuroscience
|
March 28, 2006
Limited influence of olanzapine on adult forebrain neural precursors in vitro
J H Councill, E S Tucker, G T Haskell, et al.
Pacing and Clinical Electrophysiology : PACE
|
August 23, 2006
Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performance
Michael D Gammage, Randy A Lieberman, Raymond Yee, et al.
Molecular Psychiatry
|
October 30, 2013
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E M P Poels, L S Kegeles, J T Kantrowitz, et al.
Neurology
|
January 1, 2016
CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients
Linda A Lieberman, Wanyong Zeng, Carol Singh, et al.
CNS Spectrums
|
December 31, 2005
From clinical research to clinical practice: a 4-year review of ziprasidone
Charles B Nemeroff, Jeffrey A Lieberman, Peter J Weiden, et al.
Journal of Clinical Microbiology
|
October 3, 2023
Evaluation of Fourier transform-infrared spectroscopy (FT-IR) as a control measure for nosocomial outbreak investigations
Gabriela Uribe, Stephen J Salipante, Lauren Curtis, et al.
British Journal of Cancer
|
August 15, 2002
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease
F H Blackhall, A D Atkinson, M B Maaya, et al.
JAMA
|
November 6, 1991
Prospective study of tardive dyskinesia incidence in the elderly
B L Saltz, M G Woerner, J M Kane, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 24, 1999
Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia
V S Basile, M Masellis, F Badri, et al.
Page
of 115